Published August 25, 2008
| Supplemental Material + Accepted Version
Journal Article
Open
Catalytic Enantioselective Alkylation of Substituted Dioxanone Enol Ethers: Ready Access to C(α)-Tetrasubstituted Hydroxyketones, Acids, and Esters
Abstract
Adaptive Alkylation: Palladium-catalyzed asymmetric alkylation enables access to fully substituted enantioenriched oxygenated stereocenters, which can be transformed easily to α-hydroxyketones, esters, and acids, providing a catalytic, enantioselective synthesis for natural products.
Additional Information
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Received: March 25, 2008; Revised: May 1, 2008; Published online: July 24, 2008. The authors thank the Takeda Pharmaceutical Company Limited of Japan (postdoctoral fellowship to M.S.), the California Tobacco-Related Disease Research Program of the University of California, Grant Number 14DT-0004 (predoctoral fellowship to J.L.R.), the NIH-NIGMS (R01 GM 080269-01), and Caltech for financial support, Materia, Inc. for their generous donation of catalyst 9 used in these studies, and Dr. S. Virgil, A. Silberstein, and Y. Segawa for experimental assistance.Attached Files
Accepted Version - nihms60669.pdf
Supplemental Material - anie_200801424_sm_miscellaneous_information.pdf
Files
nihms60669.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:7c23982802ef431fce5e76dc8009e187
|
395.9 kB | Preview Download |
|
md5:c669f488824b381f5f76963ade82b8fc
|
683.3 kB | Preview Download |
Additional details
- PMCID
- PMC2762748
- Eprint ID
- 74346
- DOI
- 10.1002/anie.200801424
- Resolver ID
- CaltechAUTHORS:20170215-154336630
- Takeda Pharmaceutical Company Limited
- California Tobacco-Related Disease Research Program
- 14DT-0004
- NIH
- R01GM080269-01
- Caltech
- Created
-
2017-02-16Created from EPrint's datestamp field
- Updated
-
2021-11-11Created from EPrint's last_modified field